Aussie mRNA vax blasts off

Australia's first homegrown mRNA Covid vaccine will finally enter human clinical trials in November, thanks to researchers from Monash Institute of Pharmaceutical Sciences (MIPS) that developed three candidates within four weeks at the beginning of the pandemic.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here